PROVECTUS BIOPHARMACEUTICALS, INC. Entity Listing, Par Value Per Share
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Entity Listing, Par Value Per Share of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-13
- PROVECTUS BIOPHARMACEUTICALS, INC. entity listing, par value per share for the quarter ending 2026-03-31 was $0.00, a 0.00% change year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. entity listing, par value per share for the quarter ending 2025-03-31 was $0.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. entity listing, par value per share for fiscal 2025 was $0.00, a 0.00% change from fiscal 2024.
- PROVECTUS BIOPHARMACEUTICALS, INC. entity listing, par value per share for fiscal 2024 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $0.00 10-K/A · filed 2025-05-16 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |